Thank you to our speakers, sponsors, and delegates who joined us in 2023 for the summit!
If you are interested in the 2024 event, please get in touch at info@hansonwade.com.
Integrate Advanced Biomarker Assessment of Neurodegeneration & Neuroinflammation to More Sensitively Translate CNS Drugs
Welcome to the Fluid & Imaging Biomarkers in Neuroscience Summit
The First Industry Forum for Translational Experts, Neuroscience Drug Sponsors & Biomarker Technology Developers to Transform Earlier Assessment of AD, PD, ALS & MS
Development and integration of validated, inexpensive, non-invasive, and reliable fluid and imaging biomarkers are critical to advance neurodegenerative and neuro-immunological drug candidates through clinical trials.
Built to provide cutting-edge insights across emerging biomarker technologies and address the current translational bottleneck hindering your pipeline’s success: the inaugural Fluid & Imaging Biomarkers in Neuroscience Summit was an unrivaled new opportunity to evaluate the latest biomarker research across AD, PD, MS & ALS, in one highly focused forum.
Translational experts and biomarker specialists from companies like Biogen, Eli Lilly, and Janssen united to engage in forward-thinking discussions to meaningfully advance biomarker assessments of neurodegenerative and neuroinflammatory disease-modifying therapeutics.
The 2023 World-Class Speaker Faculty Included:
Proud to Have Partnered With
Other Events in the World CNS Series:
